Volume 14 Supplement 1
Pediatric tumours: liver tumours
- Alexander J Towbin1
© Towbin; licensee BioMed Central Ltd. 2014
Published: 9 October 2014
Pediatric liver tumors account for approximately 1% of all liver tumors and up to 2% of all pediatric malignancies [1, 2]. While the overall incidence of liver tumors is rare, the liver remains the third most common organ of origin for solid abdominal tumors in the pediatric population . The majority of pediatric liver tumors, both benign and malignant, occur (almost) exclusively in children.
Benign tumors account for one-third of all pediatric hepatic neoplasms and include infantile hepatic hemangioma, focal nodular hyperplasia, mesenchymal hamartoma, and hepatic adenoma [2–5]. Malignant neoplasms account for the remaining two-thirds of pediatric liver tumors. The most common malignancies are hepatoblastoma, hepatocellular carcinoma, fibrolamellar hepatocellular carcinoma, undifferentiated embryonal sarcoma, and biliary rhabdomyosarcoma [4–6]. While the majority of these tumors are unique to children, focal nodular hyperplasia, hepatocellular adenomas, and hepatocellular carcinoma have counterparts in adults. The presentation, risk factors, and imaging appearance of these overlapping tumors differs in the pediatric population as compared to adults [7, 8].
Even though there are a number of different liver tumors, the radiologist can often make a confident diagnosis based on the clinical information and imaging appearance of the mass [9, 10]. The purpose of this lecture is to describe the imaging work-up for pediatric liver masses and then discuss each tumor, focusing on its unique clinical and imaging features.
- von Schweinitz D: Management of liver tumors in childhood. Semin Pediatr Surg 2006, 15: 17–24. 10.1053/j.sempedsurg.2005.11.004PubMedView ArticleGoogle Scholar
- Hadzic N, Finegold MJ: Liver neoplasia in children. Clin Liver Dis 2011, 15: 443–62. 10.1016/j.cld.2011.03.011PubMedView ArticleGoogle Scholar
- Kochin IN, Miloh TA, Arnon R, Iyer KR, Suchy FJ, Kerkar N: Benign liver masses and lesions in children: 53 cases over 12 years. Isr Med Assoc J 2011, 13: 542–7.PubMedGoogle Scholar
- Chung EM, Cube R, Lewis RB, Conran RM: From the archives of the AFIP: Pediatric liver masses: radiologic-pathologic correlation part 1. Benign tumors. Radiographics 2010, 30: 801–26. 10.1148/rg.303095173PubMedView ArticleGoogle Scholar
- Meyers RL: Tumors of the liver in children. Surg Oncol 2007, 16: 195–203. 10.1016/j.suronc.2007.07.002PubMedView ArticleGoogle Scholar
- Chung EM, Lattin GE Jr, Cube R, Lewis RB, Marichal-Hernández C, Shawhan R, Conran RM: From the archives of the AFIP: Pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics 2011, 31: 483–507. 10.1148/rg.312105201PubMedView ArticleGoogle Scholar
- Towbin AJ, Luo GG, Yin H, Mo JQ: Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol 2011, 41: 341–9. 10.1007/s00247-010-1839-8PubMedView ArticleGoogle Scholar
- Smith EA, Salisbury S, Martin R, Towbin AJ: Incidence and etiology of new liver lesions in pediatric patients previously treated for malignancy. AJR Am J Roentgenol 2012, 199: 186–91. 10.2214/AJR.11.7690PubMedView ArticleGoogle Scholar
- Meyers AB, Towbin AJ, Serai S, Geller JI, Podberesky DJ: Characterization of pediatric liver lesions with gadoxetate disodium. Pediatr Radiol 2011, 41: 1183–97. 10.1007/s00247-011-2148-6PubMedView ArticleGoogle Scholar
- Meyers AB, Towbin AJ, Geller JI, Podberesky DJ: Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation. Pediatr Radiol 2012, 42: 859–66. 10.1007/s00247-012-2366-6PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.